IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) represents the most common form of non-Hodgkin lymphoma (NHL) that is still incurable in a large fraction of patients. Tetraspanin CD37 is highly expressed on mature B lymphocytes, and multiple CD37-targeting therapies are under clinical development for NHL. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Elfrink, Suraya, ter Beest, Martin, Janssen, Luuk, Baltissen, Marijke P., Jansen, Pascal W. T. C., Kenyon, Angelique N., Steen, Raymond M., de Windt, Daynelys, Hagemann, Philipp M., Hess, Corine, van Spronsen, Dick-Johan, Hoevenaars, Brigiet, van der Spek, Ellen, Xu-Monette, Zijun Y., Young, Ken H., Kaffa, Charlotte, Bervoets, Sander, van Heek, Jolien, Hesius, Eva, de Winde, Charlotte M., Vermeulen, Michiel, van den Brand, Michiel, Scheijen, Blanca, van Spriel, Annemiek B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006271/
https://www.ncbi.nlm.nih.gov/pubmed/35086136
http://dx.doi.org/10.1182/bloodadvances.2021004366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006271/
https://www.ncbi.nlm.nih.gov/pubmed/35086136
http://dx.doi.org/10.1182/bloodadvances.2021004366

Ejemplares similares